Stock Scorecard
Stock Summary for Jazz Pharmaceuticals plc (JAZZ) - $115.42 as of 11/20/2024 4:14:24 PM EST
Total Score
14 out of 30
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for JAZZ
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for JAZZ
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for JAZZ
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for JAZZ
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for JAZZ (59 out of 90)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 8 |
Latest News for for JAZZ
Financial Details for JAZZ
Company Overview |
|
|---|---|
| Ticker | JAZZ |
| Company Name | Jazz Pharmaceuticals plc |
| Country | USA |
| Description | Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Dublin, Ireland. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 115.42 |
| Price 4 Years Ago | 165.05 |
| Last Day Price Updated | 11/20/2024 4:14:24 PM EST |
| Last Day Volume | 406,858 |
| Average Daily Volume | 638,130 |
| 52-Week High | 134.17 |
| 52-Week Low | 99.06 |
| Last Price to 52 Week Low | 16.52% |
Valuation Measures |
|
| Trailing PE | 16.66 |
| Industry PE | 22.60 |
| Sector PE | 40.32 |
| 5-Year Average PE | 9.51 |
| Free Cash Flow Ratio | 3.15 |
| Industry Free Cash Flow Ratio | 12.03 |
| Sector Free Cash Flow Ratio | 27.97 |
| Current Ratio Most Recent Quarter | 4.26 |
| Total Cash Per Share | 36.69 |
| Book Value Per Share Most Recent Quarter | 69.01 |
| Price to Book Ratio | 1.69 |
| Industry Price to Book Ratio | 5.31 |
| Sector Price to Book Ratio | 20.88 |
| Price to Sales Ratio Twelve Trailing Months | 1.77 |
| Industry Price to Sales Ratio Twelve Trailing Months | 11.82 |
| Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 7 |
Share Statistics |
|
| Total Shares Outstanding | 60,455,000 |
| Market Capitalization | 6,977,716,100 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 2.75% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 59.70% |
| Annual Earnings Growth | 285.14% |
| Reported EPS 12 Trailing Months | 7.01 |
| Reported EPS Past Year | 14.59 |
| Reported EPS Prior Year | 18.32 |
| Net Income Twelve Trailing Months | 463,159,000 |
| Net Income Past Year | 414,832,000 |
| Net Income Prior Year | -224,060,000 |
| Quarterly Revenue Growth YOY | 8.50% |
| 5-Year Revenue Growth | 15.04% |
| Operating Margin Twelve Trailing Months | 0.25 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 2,218,135,000 |
| Total Cash Past Year | 1,506,310,000 |
| Total Cash Prior Year | 881,482,000 |
| Net Cash Position Most Recent Quarter | -3,893,667,000 |
| Net Cash Position Past Year | -4,206,632,000 |
| Long Term Debt Past Year | 5,712,942,000 |
| Long Term Debt Prior Year | 5,724,341,000 |
| Total Debt Most Recent Quarter | 6,111,802,000 |
| Equity to Debt Ratio Past Year | 0.40 |
| Equity to Debt Ratio Most Recent Quarter | 0.41 |
| Total Stockholder Equity Past Year | 3,736,997,000 |
| Total Stockholder Equity Prior Year | 3,085,734,000 |
| Total Stockholder Equity Most Recent Quarter | 4,171,067,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,129,782,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 18.69 |
| Free Cash Flow Past Year | 1,068,045,000 |
| Free Cash Flow Prior Year | 1,217,931,000 |
Options |
|
| Put/Call Ratio | 0.16 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 3.81 |
| MACD Signal | 2.01 |
| 20-Day Bollinger Lower Band | 101.18 |
| 20-Day Bollinger Middle Band | 111.58 |
| 20-Day Bollinger Upper Band | 121.98 |
| Beta | 0.57 |
| RSI | 73.73 |
| 50-Day SMA | 114.49 |
| 150-Day SMA | 133.64 |
| 200-Day SMA | 139.09 |
System |
|
| Modified | 11/21/2024 4:23:39 AM EST |